Heartflow Inc (HTFL)

$28.67 +0.22 (0.77%)
Market Cap 2.42B
Revenue (ttm) 176.03M
Net Income (ttm) -116.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -66.35%
Debt to Equity Ratio 0.00
Volume 652,014
Avg Vol 1,177,490
Day's Range N/A - N/A
Shares Out 86.24M
Stochastic %K 16%
Beta N/A
Analysts Strong Sell
Price Target $37.00

Company Profile

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anat...

Industry: Health Information Services
Sector: Healthcare
Phone: 650 241 1221
Address:
135 Main Street, Suite 1000, San Francisco, United States
LewisDaKat
LewisDaKat May. 31 at 12:00 PM
$HTFL Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? https://marketwirenews.com/stock/htfl/news/is-heartflow-stock-a-buy-after-an-institutional-inve-4787568265673733.html?utm_source=stocktwits
0 · Reply
OMillionaires
OMillionaires May. 28 at 5:51 PM
This $HTFL is one of the best stories out there. AI, Healthcare, coverage from insurers... Tackling the leading cause of death in the U.S. This is a $100+ stock in the coming 6-12 months IMHO(if company executes)
0 · Reply
romura
romura May. 22 at 8:37 PM
$HTFL will hit $35 to 36 next week, I was 31.50 this morning. very positive news
0 · Reply
BioGem
BioGem May. 21 at 1:02 PM
$HTFL A short position here is not unreasonable. It is extremely overvalued at anything above 20 dollars: -Valuation on EV/Sales ratio is through the roof. -Growth will be slowing sharply by next year. -While operating expenses expanding the sales team is skyrocketing. -Losses and cash burn are accelerating. -Cash is dwindling and they will need a capital raise in the near future. -Too many stock awards given cheaply in the money, and insiders can't stop selling their shares to retail. -Analysts have lowered their price targets post Q1 report.
0 · Reply
05ford
05ford May. 15 at 7:14 PM
$HTFL why the big drop today?
0 · Reply
OpenOutcrier
OpenOutcrier May. 15 at 12:37 PM
$HTFL (-0.7% pre) Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance https://ooc.bz/l/102484
0 · Reply
OMillionaires
OMillionaires May. 15 at 11:03 AM
$HTFL PT raised to $37 from $35 at Wells Fargo - keeps Overweight rating
0 · Reply
MarketBeat
MarketBeat May. 15 at 1:10 AM
https://marketbeat.com/a/8655143/ $HTFL Heartflow Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 15 at 12:02 AM
https://www.marketbeat.com/earnings/reports/2026-5-14-heartflow-inc-stock/ $HTFL Heartflow Earnings Transcript
0 · Reply
Doozio
Doozio May. 14 at 11:25 PM
$HTFL ONTO 🐒🍌🧠⏰♾️
0 · Reply
Latest News on HTFL
Heartflow price target lowered to $37 from $43 at Canaccord

2026-05-15T11:25:34.000Z - 25 days ago

Heartflow price target lowered to $37 from $43 at Canaccord

Heartflow price target raised to $37 from $35 at Wells Fargo

2026-05-15T11:08:49.000Z - 25 days ago

Heartflow price target raised to $37 from $35 at Wells Fargo

Heartflow reports Q1 EPS (32c), consensus (17c)

2026-05-14T21:07:40.000Z - 25 days ago

Heartflow reports Q1 EPS (32c), consensus (17c)

Heartflow raises FY26 revenue view to $228M-$232M from $218M-$22M

2026-05-14T21:01:17.000Z - 25 days ago

Heartflow raises FY26 revenue view to $228M-$232M from $218M-$22M

HeartFlow Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 25 days ago

HeartFlow Earnings Call Transcript: Q1 2026

HeartFlow Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 25 days ago

HeartFlow Earnings release: Q1 2026

HeartFlow Quarterly report: Q1 2026

May 14, 2026, 4:30 PM EDT - 25 days ago

HeartFlow Quarterly report: Q1 2026

Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

May 14, 2026, 4:01 PM EDT - 26 days ago

Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

Heartflow initiated with an Outperform at William Blair

2026-05-04T10:26:10.000Z - 5 weeks ago

Heartflow initiated with an Outperform at William Blair

HeartFlow Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

HeartFlow Proxy statement: Proxy filing

HeartFlow Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

HeartFlow Proxy statement: Proxy filing

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

Apr 23, 2026, 4:05 PM EDT - 6 weeks ago

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

Heartflow files patent infringement lawsuit against Cleerly

2026-04-13T13:04:47.000Z - 2 months ago

Heartflow files patent infringement lawsuit against Cleerly

Heartflow Files Patent Infringement Lawsuit Against Cleerly

Apr 13, 2026, 8:30 AM EDT - 2 months ago

Heartflow Files Patent Infringement Lawsuit Against Cleerly

Heartflow price target lowered to $35 from $40 at JPMorgan

2026-03-19T11:52:57.000Z - 2 months ago

Heartflow price target lowered to $35 from $40 at JPMorgan

Heartflow price target raised to $43 from $40 at Canaccord

2026-03-19T10:47:04.000Z - 2 months ago

Heartflow price target raised to $43 from $40 at Canaccord

HeartFlow Earnings Call Transcript: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 2 months ago

HeartFlow Earnings Call Transcript: Q4 2025

HeartFlow Annual report: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 2 months ago

HeartFlow Annual report: Q4 2025

HeartFlow Earnings release: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 2 months ago

HeartFlow Earnings release: Q4 2025

Heartflow reports Q4 EPS (29c), consensus (16c)

2026-03-18T20:21:23.000Z - 2 months ago

Heartflow reports Q4 EPS (29c), consensus (16c)

Heartflow sees FY26 revenue $218M-$22M, consensus $212.94M

2026-03-18T20:20:18.000Z - 2 months ago

Heartflow sees FY26 revenue $218M-$22M, consensus $212.94M

Heartflow announces clinical evidence, landmark registry launch

2026-03-16T12:12:03.000Z - 3 months ago

Heartflow announces clinical evidence, landmark registry launch

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Mar 16, 2026, 8:00 AM EDT - 3 months ago

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

HeartFlow Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Mar 3, 2026, 1:45 PM EST - 3 months ago

HeartFlow Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Feb 18, 2026, 4:05 PM EST - 3 months ago

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Feb 13, 2026, 4:21 PM EST - 4 months ago

Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Heartflow announces expansion of its GAMEFILM Registry

2026-02-12T13:10:42.000Z - 4 months ago

Heartflow announces expansion of its GAMEFILM Registry

Heartflow initiated with an Overweight at Wells Fargo

2026-01-28T10:20:29.000Z - 4 months ago

Heartflow initiated with an Overweight at Wells Fargo

HeartFlow Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 4:30 PM EST - 5 months ago

HeartFlow Transcript: 44th Annual J.P. Morgan Healthcare Conference

HeartFlow Slides: Investor presentation

Jan 12, 2026, 7:00 AM EST - 5 months ago

HeartFlow Slides: Investor presentation

Heartflow announces Plaque Analysis covered by Aetna insurance plans

2026-01-06T13:16:03.000Z - 5 months ago

Heartflow announces Plaque Analysis covered by Aetna insurance plans

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

Jan 6, 2026, 8:00 AM EST - 5 months ago

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 4:05 PM EST - 5 months ago

Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference

ACC, AHA publish scientific statements supporting Heartflow plaque analysis

2025-12-18T21:25:37.000Z - 6 months ago

ACC, AHA publish scientific statements supporting Heartflow plaque analysis

Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD

Dec 18, 2025, 4:05 PM EST - 6 months ago

Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD

Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease

Dec 11, 2025, 3:10 AM EST - 6 months ago

Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease

HeartFlow Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 3:30 PM EST - 6 months ago

HeartFlow Transcript: Piper Sandler 37th Annual Healthcare Conference

Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 4:33 PM EST - 7 months ago

Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference

Heartflow price target raised to $40 from $35 at Stifel

2025-11-13T13:00:53.000Z - 7 months ago

Heartflow price target raised to $40 from $35 at Stifel

HeartFlow Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 7 months ago

HeartFlow Earnings Call Transcript: Q3 2025

HeartFlow Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 7 months ago

HeartFlow Quarterly report: Q3 2025

HeartFlow Earnings release: Q3 2025

Nov 12, 2025, 4:30 PM EST - 7 months ago

HeartFlow Earnings release: Q3 2025

Heartflow Reports Third Quarter 2025 Financial Results

Nov 12, 2025, 4:01 PM EST - 7 months ago

Heartflow Reports Third Quarter 2025 Financial Results

AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification

Nov 9, 2025, 1:30 PM EST - 7 months ago

AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification

Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025

Nov 3, 2025, 8:00 AM EST - 7 months ago

Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025

Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025

Oct 23, 2025, 4:05 PM EDT - 8 months ago

Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025

New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning

Oct 22, 2025, 8:00 AM EDT - 8 months ago

New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform

Sep 22, 2025, 4:05 PM EDT - 9 months ago

Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform

HeartFlow Quarterly report: Q2 2025

Sep 19, 2025, 8:30 AM EDT - 9 months ago

HeartFlow Quarterly report: Q2 2025

HeartFlow Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 10, 2025, 9:15 AM EDT - 9 months ago

HeartFlow Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

HeartFlow Slides: Investor Presentation

Sep 9, 2025, 6:00 PM EDT - 9 months ago

HeartFlow Slides: Investor Presentation

Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 27, 2025, 4:24 PM EDT - 10 months ago

Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Aug 11, 2025, 4:30 PM EDT - 10 months ago

Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Heartflow Stock Opens Nearly 50% Above IPO Price in Latest Hot Debut

Aug 8, 2025, 1:58 PM EDT - 10 months ago

Heartflow Stock Opens Nearly 50% Above IPO Price in Latest Hot Debut

Medtech firm Heartflow gains 47% in solid Nasdaq debut

Aug 8, 2025, 1:05 PM EDT - 10 months ago

Medtech firm Heartflow gains 47% in solid Nasdaq debut

Medtech firm Heartflow raises $316.7 million in US IPO

Aug 7, 2025, 8:54 PM EDT - 10 months ago

Medtech firm Heartflow raises $316.7 million in US IPO

Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering

Aug 7, 2025, 8:27 PM EDT - 10 months ago

Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering

HeartFlow Registration statement: Registration Filing

Aug 6, 2025, 8:00 AM EDT - 10 months ago

HeartFlow Registration statement: Registration Filing

Bain Capital-backed Heartflow targets $1.5 billion valuation in upsized US IPO

Aug 6, 2025, 7:57 AM EDT - 10 months ago

Bain Capital-backed Heartflow targets $1.5 billion valuation in upsized US IPO

Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation

Aug 6, 2025, 4:48 AM EDT - 10 months ago

Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation

Bain Capital-backed Heartflow eyes $1.3 billion valuation in US IPO

Aug 1, 2025, 8:16 AM EDT - 11 months ago

Bain Capital-backed Heartflow eyes $1.3 billion valuation in US IPO

HeartFlow Registration statement: Registration Filing

Aug 1, 2025, 8:00 AM EDT - 11 months ago

HeartFlow Registration statement: Registration Filing

Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

Jul 22, 2025, 6:28 PM EDT - 11 months ago

Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide

LewisDaKat
LewisDaKat May. 31 at 12:00 PM
$HTFL Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? https://marketwirenews.com/stock/htfl/news/is-heartflow-stock-a-buy-after-an-institutional-inve-4787568265673733.html?utm_source=stocktwits
0 · Reply
OMillionaires
OMillionaires May. 28 at 5:51 PM
This $HTFL is one of the best stories out there. AI, Healthcare, coverage from insurers... Tackling the leading cause of death in the U.S. This is a $100+ stock in the coming 6-12 months IMHO(if company executes)
0 · Reply
romura
romura May. 22 at 8:37 PM
$HTFL will hit $35 to 36 next week, I was 31.50 this morning. very positive news
0 · Reply
BioGem
BioGem May. 21 at 1:02 PM
$HTFL A short position here is not unreasonable. It is extremely overvalued at anything above 20 dollars: -Valuation on EV/Sales ratio is through the roof. -Growth will be slowing sharply by next year. -While operating expenses expanding the sales team is skyrocketing. -Losses and cash burn are accelerating. -Cash is dwindling and they will need a capital raise in the near future. -Too many stock awards given cheaply in the money, and insiders can't stop selling their shares to retail. -Analysts have lowered their price targets post Q1 report.
0 · Reply
05ford
05ford May. 15 at 7:14 PM
$HTFL why the big drop today?
0 · Reply
OpenOutcrier
OpenOutcrier May. 15 at 12:37 PM
$HTFL (-0.7% pre) Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance https://ooc.bz/l/102484
0 · Reply
OMillionaires
OMillionaires May. 15 at 11:03 AM
$HTFL PT raised to $37 from $35 at Wells Fargo - keeps Overweight rating
0 · Reply
MarketBeat
MarketBeat May. 15 at 1:10 AM
https://marketbeat.com/a/8655143/ $HTFL Heartflow Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 15 at 12:02 AM
https://www.marketbeat.com/earnings/reports/2026-5-14-heartflow-inc-stock/ $HTFL Heartflow Earnings Transcript
0 · Reply
Doozio
Doozio May. 14 at 11:25 PM
$HTFL ONTO 🐒🍌🧠⏰♾️
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 14 at 8:09 PM
$HTFL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.32 up 93.90% YoY • Reported revenue of $52.59M up 41.34% YoY • Heartflow raised its full-year 2026 total revenue guidance to $228M to $232M, representing 29% to 32% growth year-over-year, and maintained Non-GAAP gross margin at approximately 81%.
0 · Reply
marley401
marley401 May. 14 at 7:57 PM
$HTFL few er lotto calls
0 · Reply
OG_Monkey_Banana_Genius
OG_Monkey_Banana_Genius May. 14 at 6:40 PM
$HTFL earnings tonight. Looks ready
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 11 at 1:07 PM
The Future of Intoxication Detection May Be in Your Voice $MBIO.CN $MBQIF $HTFL $RXRX $TEM $BFLY https://ibn.fm/hAnhh
0 · Reply
SuperGreenToday
SuperGreenToday May. 4 at 6:55 PM
$HTFL Share Price: $28.87 Contract Selected: Oct 16, 2026 $30 Calls Buy Zone: $3.57 – $4.41 Target Zone: $6.78 – $8.29 Potential Upside: 79% ROI Time to Expiration: 164 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
FilingTracker
FilingTracker May. 1 at 1:12 PM
$HTFL Massive insider sale: https://www.sec.gov/Archives/edgar/data/1464521/000119312526198593/xslF345X06/ownership.xml
0 · Reply
Davy_Stockett
Davy_Stockett Apr. 16 at 6:38 PM
$HTFL
0 · Reply
Iggymed
Iggymed Apr. 14 at 3:47 PM
$HTFL lookin good
0 · Reply
Thr0winDarts
Thr0winDarts Mar. 30 at 2:06 PM
$HTFL this dog shit gonna reverse or what
0 · Reply
Thr0winDarts
Thr0winDarts Mar. 26 at 7:00 PM
$HTFL I bought this back at 26.60 today. It’s destined to get crushed again now. Already down a buck
1 · Reply
healthcareguru
healthcareguru Mar. 19 at 1:56 PM
$HTFL nonsense move…going back <$20…lots of PE secondaries coming after lackluster print and slowing growth ahead; insanity valuation.👎 $XLV $IHI $IWM
1 · Reply